AngioDynamics, Inc. Revenues
AngioDynamics, Inc. (ANGO) reported Revenues of $291.01 million for the 12-month period ending 2021-05-31, per its 10-K filed 2021-07-27.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2021-07-27
- AngioDynamics, Inc. revenues for the quarter ending 2021-05-31 was $76.84M, a 31.73% increase year-over-year.
- AngioDynamics, Inc. revenues for the quarter ending 2021-02-28 was $71.18M, a 2.01% increase year-over-year.
- AngioDynamics, Inc. revenues for the quarter ending 2020-11-30 was $72.77M, a 3.95% increase year-over-year.
- AngioDynamics, Inc. revenues for the quarter ending 2020-08-31 was $70.22M, a 6.32% increase year-over-year.
- AngioDynamics, Inc. revenues for fiscal 2021 was $291.01M, a 10.17% increase from fiscal 2020.
- AngioDynamics, Inc. revenues for fiscal 2020 was $264.16M, a 2.39% decline from fiscal 2019.
- AngioDynamics, Inc. revenues for fiscal 2019 was $270.63M, a 3.43% increase from fiscal 2018.
- AngioDynamics, Inc. revenues for fiscal 2018 was $261.65M, a 3.01% decline from fiscal 2017.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-05-31 | $76.84M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-27 | $148.02M derived: sum of 2 quarters · filed 2021-07-27 | $220.79M derived: sum of 3 quarters · filed 2021-07-27 | $291.01M 10-K · filed 2021-07-27 | ||||
| 2021-02-28 | $71.18M 10-Q · filed 2021-03-31 | $143.95M derived: sum of 2 quarters · filed 2021-03-31 | $214.17M 10-Q · filed 2021-03-31 | $272.50M derived: sum of 4 quarters · filed 2021-03-31 | ||||
| 2020-11-30 | $72.77M 10-Q · filed 2021-01-08 | $142.99M 10-Q · filed 2021-01-08 | $201.32M derived: sum of 3 quarters · filed 2021-01-08 | $271.10M derived: sum of 4 quarters · filed 2021-03-31 | ||||
| 2020-08-31 | $70.22M 10-Q · filed 2020-10-07 | $128.55M derived: sum of 2 quarters · filed 2020-10-07 | $198.33M derived: sum of 3 quarters · filed 2021-03-31 | $268.33M derived: sum of 4 quarters · filed 2021-03-31 | ||||
| 2020-05-31 | $58.33M 10-K · filed 2020-08-10 | $128.11M derived: sum of 2 quarters · filed 2021-03-31 | $198.12M derived: sum of 3 quarters · filed 2021-03-31 | $264.16M 10-K · filed 2021-07-27 | ||||
| 2020-02-29 | $69.78M 10-Q · filed 2021-03-31 | $139.78M derived: sum of 2 quarters · filed 2021-03-31 | $205.82M 10-Q · filed 2021-03-31 | $277.01M derived: sum of 4 quarters · filed 2021-03-31 | ||||
| 2019-11-30 | $70.00M 10-Q · filed 2021-01-08 | $136.04M 10-Q · filed 2021-01-08 | $207.23M derived: sum of 3 quarters · filed 2021-01-08 | $272.75M derived: sum of 4 quarters · filed 2021-01-08 | ||||
| 2019-08-31 | $66.04M 10-Q · filed 2020-10-07 | $137.22M derived: sum of 2 quarters · filed 2020-10-07 | $202.75M derived: sum of 3 quarters · filed 2020-10-07 | $272.73M derived: sum of 4 quarters · filed 2020-10-07 | ||||
| 2019-05-31 | $71.18M 10-K · filed 2020-08-10 | $136.71M derived: sum of 2 quarters · filed 2020-08-10 | $206.69M derived: sum of 3 quarters · filed 2020-08-10 | $270.63M 10-K · filed 2021-07-27 | ||||
| 2019-02-28 | $65.52M 10-K · filed 2020-08-10 | $86.34M 10-Q · filed 2019-04-02 | $135.51M derived: sum of 2 quarters · filed 2020-08-10 | $199.45M 10-Q · filed 2020-04-08 | $263.18M 10-Q · filed 2019-04-02 | $265.64M derived: sum of 4 quarters · filed 2020-08-10 | ||
| 2018-11-30 | $69.98M 10-K · filed 2020-08-10 | $91.50M 10-Q · filed 2019-01-07 | $133.93M 10-Q · filed 2020-01-08 | $176.84M 10-Q · filed 2019-01-07 | $200.12M derived: sum of 3 quarters · filed 2020-08-10 | $264.06M derived: sum of 4 quarters · filed 2020-08-10 | ||
| 2018-08-31 | $63.94M 10-K · filed 2020-08-10 | $85.34M 10-Q · filed 2018-10-01 | $130.14M derived: sum of 2 quarters · filed 2020-08-10 | $194.07M derived: sum of 3 quarters · filed 2020-08-10 | $260.69M derived: sum of 4 quarters · filed 2020-08-10 | |||
| 2018-05-31 | $66.19M 10-K · filed 2019-07-25 | $88.32M 10-K · filed 2018-07-23 | $130.13M derived: sum of 2 quarters · filed 2019-07-25 | $196.75M derived: sum of 3 quarters · filed 2019-07-25 | $261.65M 10-K · filed 2020-08-10 | $344.29M 10-K · filed 2018-07-23 | ||
| 2018-02-28 | $63.94M 10-K · filed 2019-07-25 | $83.85M 10-K · filed 2018-07-23 | $130.55M derived: sum of 2 quarters · filed 2019-07-25 | $255.97M 10-Q · filed 2019-04-02 | $282.38M derived: sum of 4 quarters · filed 2019-07-25 | |||
| 2017-11-30 | $66.62M 10-K · filed 2019-07-25 | $86.71M 10-K · filed 2018-07-23 | $172.12M 10-Q · filed 2019-01-07 | $218.44M derived: sum of 3 quarters · filed 2019-07-25 | $304.04M derived: sum of 4 quarters · filed 2019-07-25 | |||
| 2017-08-31 | $64.91M 10-K · filed 2019-07-25 | $85.41M 10-K · filed 2018-07-23 | $151.82M derived: sum of 2 quarters · filed 2019-07-25 | $237.43M derived: sum of 3 quarters · filed 2019-07-25 | $326.45M derived: sum of 4 quarters · filed 2019-07-25 | |||
| 2017-05-31 | $86.91M 10-K · filed 2018-07-23 | $172.52M derived: sum of 2 quarters · filed 2018-07-23 | $261.55M derived: sum of 3 quarters · filed 2018-07-23 | $269.79M 10-K · filed 2019-07-25 | $349.64M 10-K · filed 2018-07-23 | |||
| 2017-02-28 | $85.60M 10-K · filed 2018-07-23 | $174.63M derived: sum of 2 quarters · filed 2018-07-23 | $262.73M derived: sum of 3 quarters · filed 2018-07-23 | |||||
| 2016-11-30 | $89.03M 10-K · filed 2018-07-23 | $177.13M derived: sum of 2 quarters · filed 2018-07-23 | ||||||
| 2016-08-31 | $88.10M 10-K · filed 2018-07-23 | |||||||
| 2016-05-31 | $353.89M 10-K · filed 2018-07-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |